Psychotic symptoms associated with topiramate: cognitive side effects or worsening of psychosis?
Duggal
Harpreet S
HS
D000208:Acute Disease; D000927:Anticonvulsants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D011569:Psychiatric Status Rating Scales; D017470:Receptors, Glutamate / Q000187:drug effects; D012559:Schizophrenia / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012720:Severity of Illness Index; D000077236:Topiramate; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D017470:Receptors, Glutamate; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid